BRIANNA ROBISON: Open Payments
NPI 1568001709 · LOGAN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$308 in 16 payments from 9 companies in 2025. Trend: 2023 $145 · 2024 $143 · 2025 $308
Food & beverage: $308
| Company | Payments | Amount |
|---|---|---|
| Hologic Sales and Service, LLC | 3 | $54 |
| Astellas Pharma US Inc | 2 | $51 |
| Sumitomo Pharma America, Inc. | 2 | $47 |
| ABBVIE INC. | 2 | $43 |
| CooperSurgical, Inc. | 2 | $37 |
| Organon LLC | 2 | $23 |
| COLOPLAST CORP | 1 | $19 |
| Exeltis, USA Inc. | 1 | $18 |
| Biogen, Inc. | 1 | $16 |
Products named: Veozah, MYFEMBREE, Paragard T 380A, UBRELVY, NEXPLANON, LILETTA, MYOSURE TISSUE REMOVAL DEVICE, Altis.
Industry payments across UT — which companies pay providers there.
